Topic: Business and Economic Policy

Kentucky Office of the Governor Communications with Sen. McConnell

April 2, 2020
Kentucky Office of the Governor emails received in response to our request for communications between select officials in the office of former Governor Matthew Bevin and Senator Mitch McConnell or his staff.

Kentucky Governor Office’s Email Communication with DOT

April 2, 2020
Email received in response to our request for communications between select officials in the office of former Kentucky Governor Matt Bevin and in the Department of Transportation.

No Records Response from Fed Regarding Shadow Banking

April 1, 2020
The Federal Reserve stated that it had no records responsive to American Oversight's request for records concerning shadow banking regulations.

USDA Rural Development Calendars for Senior Officials

April 1, 2020
Records from the U.S. Department of Agriculture in response to American Oversight's request for calendars of former Assistant to the Secretary for Rural Development Anne Hazlett and Acting Assistant to the Secretary for Rural Development Joel Baxley.

FOIA to BIS Seeking Directives Regarding the Defense Production Act

April 1, 2020
FOIA to BIS seeking directives and guidance regarding the implementation of the Defense Production Act

FOIA to Commerce Seeking Email Communications of Senior Leadership

April 1, 2020
FOIA to Commerce seeking email communications of senior leadership related to coronavirus.

FOIA to BIS Seeking Email Communications of Senior Leadership

April 1, 2020
FOIA to BIS seeking email communications of senior leadership related to coronavirus.

FOIA to Commerce Seeking Directives Regarding the Defense Production Act

April 1, 2020
FOIA to Commerce seeking directives and guidance regarding the implementation of the Defense Production Act

News Roundup: Transparency and Oversight Are More Important Than Ever

March 27, 2020
During ordinary times, government transparency maintains a functioning democracy. But during the coronavirus outbreak, it can also save lives.

FOIA to FDA Seeking Records Sufficient to Identify Date Gilead Submitted Orphan Drug Designation Request for COVID-19 Treatment

March 27, 2020
FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19.